Poddar Ujjal, Thapa Babu Ram, Nain Chander Kanwal, Prasad Arun, Singh Kartar
Division of Pediatric Gastroenterology, Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
J Pediatr Gastroenterol Nutr. 2002 Oct;35(4):508-12. doi: 10.1097/00005176-200210000-00009.
In a developing country, many conditions other then celiac disease (CD) can give rise to villous atrophy. We therefore assessed the role of immunoglobulin A (IgA)-antigliadin antibody (AGA) in addition to the ESPGHAN criteria in the diagnosis of CD in 104 Indian children.
Consecutive children with suspected CD were evaluated over 3 years with an intention to diagnose CD. Complete hemogram, d-xylose absorption test, endoscopic duodenal biopsy, and IgA-AGA titers were performed in all. CD was diagnosed on the basis of modified ESPGHAN criteria irrespective of IgA-AGA positivity (>5 U/mL), and those diagnosed were put on gluten-free diet and were monitored regularly. Children with suspected CD who had a normal duodenal biopsy result were taken as controls.
The mean age of 50 children with CD was 6.3 +/- 2.6 years, with a male to female ratio of 3:2. The mean duration of symptoms was 3.4 +/- 2.2 years. Predominant symptoms were pallor in 96%, failure to thrive in 92%, and diarrhea in 80%. On follow-up (19.6 +/- 8 months), symptoms subsided within 16 +/- 9.8 days, and patients showed significant weight gain (mean weight at diagnoses and at last follow-up visit were 66% and 86% of expected, respectively; P < 0.001) and height gain (mean height at diagnoses and at last follow-up visit were 88% and 94% of expected, respectively; P = nonsignificant). The control group comprised 47 children with a mean age of 6.9 +/- 3 years. On comparing CD with controls, diarrhea, anemia, low weight, and stunting were significantly (P < 0.001) more frequent in patients with CD. Sensitivity and specificity of AGA at a cutoff value of 5 U/mL were 94% and 91.5% and at 10 U/mL 88% and 100%, respectively. Follow-up AGA test was performed in 42 of 47 positive cases. All showed significant decrease in AGA titer, and 29 (70%) had a negative test result.
Indian children with CD are true cases of CD. They present late, diarrhea is absent in 20% of cases, and AGA test results show 88% of children without false-positive results at a cutoff value of 10 U/mL. However, AGA test with 94% sensitivity at a cutoff value of 5 U/mL can be used as screening test to select suspected cases for further workup.
在一个发展中国家,除乳糜泻(CD)外,许多其他病症也可导致绒毛萎缩。因此,我们评估了免疫球蛋白A(IgA)-抗麦醇溶蛋白抗体(AGA)在104名印度儿童CD诊断中的作用,此外还评估了欧洲儿科胃肠病、肝病和营养学会(ESPGHAN)标准的作用。
对连续3年疑似患有CD的儿童进行评估,以诊断CD。所有儿童均进行了全血细胞计数、d-木糖吸收试验、内镜下十二指肠活检以及IgA-AGA滴度检测。根据改良的ESPGHAN标准诊断CD,无论IgA-AGA是否呈阳性(>5 U/mL),对诊断出的患儿采用无麸质饮食,并定期进行监测。十二指肠活检结果正常的疑似CD儿童作为对照。
50名CD患儿的平均年龄为6.3±2.6岁,男女比例为3:2。症状的平均持续时间为3.4±2.2年。主要症状为面色苍白(96%)、发育不良(92%)和腹泻(80%)。随访(19.6±8个月)时,症状在16±9.8天内缓解,患者体重显著增加(诊断时和最后一次随访时的平均体重分别为预期体重的66%和86%;P<0.001),身高也显著增加(诊断时和最后一次随访时的平均身高分别为预期身高的88%和94%;P=无显著差异)。对照组包括47名儿童,平均年龄为6.9±3岁。与对照组相比,CD患者腹泻、贫血、体重低和发育迟缓的发生率显著更高(P<0.001)。AGA在临界值为5 U/mL时的敏感性和特异性分别为94%和91.5%,在临界值为10 U/mL时分别为88%和100%。47例阳性病例中有42例进行了随访AGA检测。所有病例的AGA滴度均显著下降,29例(70%)检测结果为阴性。
印度CD患儿确诊为CD。他们就诊较晚,20%的病例无腹泻症状,在临界值为10 U/mL时,AGA检测结果显示88%的儿童无假阳性结果。然而,临界值为5 U/mL时敏感性为94%的AGA检测可作为筛查试验,以选择疑似病例进行进一步检查。